1-15 of 15
Andrew Srisuwananukorn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis

Douglas Tremblay, Zaker I. Schwabkey, Yosef Joseph Rene Amel Riazat-Kesh, Grace Van Hyfte, Najla H Al Ali, Julian Waksal, Andrew Srisuwananukorn, Rami S. Komrokji, John Mascarenhas, Andrew T. Kuykendall
Journal: Blood
Blood (2023) 142 (Supplement 1): 1830.
https://doi.org/10.1182/blood-2023-179937
Published: 2023
Journal Articles

Interpretable Artificial Intelligence (AI) Differentiates Prefibrotic Primary Myelofibrosis (prePMF) from Essential Thrombocythemia (ET): A Multi-Center Study of a New Clinical Decision Support Tool

Andrew Srisuwananukorn, Giuseppe Gaetano Loscocco, Andrew T. Kuykendall, James M Dolezal, Raffaella Santi, Ling Zhang, Avani M Singh, Paola Guglielmelli, Alessandro Maria Vannucchi, Douglas Tremblay, Alexander T Pearson, Mohamed E. Salama, Ronald Hoffman
Journal: Blood
Blood (2023) 142 (Supplement 1): 901.
https://doi.org/10.1182/blood-2023-173877
Published: 2023
Journal Articles

Oral Decitabine/Cedazuridine Is a Tolerable and Effective Ambulatory Regimen for Patients with Advanced Myeloproliferative Neoplasms

Ganesh Sivakumar, Shivani Handa, Andrew Srisuwananukorn, Douglas Tremblay, John Mascarenhas, Marina Kremyanskaya, Yelena Ginzburg, Xiaoli Wang, Ronald Hoffman
Journal: Blood
Blood (2023) 142 (Supplement 1): 1828.
https://doi.org/10.1182/blood-2023-178822
Published: 2023
Journal Articles

Predictors and Clinical Complications Associated with Antiphospholipid Antibodies in Sickle Cell Disease

Claudia Rodriguez Rivera, Andrew Srisuwananukorn, Rizma Jalees Bajwa, Victor R. Gordeuk, Joyce Rauch, Jerrold Levine, Santosh L. Saraf
Journal: Blood
Blood (2022) 140 (Supplement 1): 8278–8279.
https://doi.org/10.1182/blood-2022-163851
Published: 2022
Journal Articles

Novel Machine Learning Algorithm Predicts Disease Progression in Polycythemia Vera (PV) with Readily-Available Baseline Characteristics

Andrew Srisuwananukorn, Beth Percha, Ghaith Abu-Zeinah, Joseph Scandura, Spencer Krichevsky, Elwood Taylor, III, Richard T. Silver, Santiago Thibaud, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew T. Kuykendall, Casey O'Connell, Jamile M. Shammo, Angela Fleischman, Ruben A. Mesa, Abdulraheem Yacoub, Ronald Hoffman, John Mascarenhas, Douglas Tremblay
Journal: Blood
Blood (2021) 138 (Supplement 1): 2583.
https://doi.org/10.1182/blood-2021-150561
Published: 2021
Journal Articles

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Risk of Thrombosis in Polycythemia Vera (PV) Patients

Ghaith Abu-Zeinah, Spencer Krichevsky, Richard T. Silver, Elwood Taylor, III, Douglas Tremblay, Andrew Srisuwananukorn, John Mascarenhas, Joseph Scandura
Journal: Blood
Blood (2021) 138 (Supplement 1): 3619.
https://doi.org/10.1182/blood-2021-149098
Published: 2021
Journal Articles

Defining and Predicting Rapid Egfr Decline in Sickle Cell Disease

Santosh L. Saraf, Jin Han, Maria Armila Ruiz, Andrew Srisuwananukorn, David Shuey, Faiz Ahmed Hussain, Franklin Njoku, Robert E. Molokie, Victor R. Gordeuk
Journal: Blood
Blood (2021) 138 (Supplement 1): 122.
https://doi.org/10.1182/blood-2021-147861
Published: 2021
Journal Articles

European Leukemianet (ELN) Response Predicts Disease Progression but Not Thrombosis or Death in Polycythemia Vera (PV): An Analysis of a Multicenter Database

Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew T. Kuykendall, Casey L. O'Connell, Jamile M. Shammo, Angela Fleischman, Ruben A. Mesa, Abdulraheem Yacoub, Ronald Hoffman, Erin Moshier, Nicole Zubizarreta, John Mascarenhas
Journal: Blood
Blood (2021) 138 (Supplement 1): 240.
https://doi.org/10.1182/blood-2021-148020
Published: 2021
Journal Articles

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Renee Cheng, MD, Andrew Srisuwananukorn, MD, Jin Han, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-137272
Published: 2020
Journal Articles

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Syeda Rahman, Andrew Srisuwananukorn, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Edith A. Nutescu, PharmD., MS, FCCP, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Jin Han
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-137166
Published: 2020
Journal Articles

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Jin Han, Andrew Srisuwananukorn, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Franklin Njoku, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-138753
Published: 2020
Journal Articles

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Mahir Khan, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Victor R. Gordeuk, MD, Franklin Njoku, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-139653
Published: 2020
Journal Articles

Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts

Jifang Zhou, MD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP, William Galanter, MD PhD MS, Surrey M. Walton, PhD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Andrew Srisuwananukorn, MD, Gregory Sampang Calip, PharmD, MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4817.
https://doi.org/10.1182/blood-2018-99-119039
Published: 2018
Journal Articles

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Shivi Jain, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1087.
https://doi.org/10.1182/blood-2018-99-115508
Published: 2018
Journal Articles

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Andrew Srisuwananukorn, MD, Rasha Raslan, MD, Xu Zhang, PhD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 9.
https://doi.org/10.1182/blood-2018-99-115128
Published: 2018